Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. embryon

EMBRYON

EMBRYON - Develop and commercialize a highly innovative diagnostic-imaging product, improving success rates in the Assisted Reproduction IVF sector

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 EMBRYON project word cloud

Explore the words cloud of the EMBRYON project. It provides you a very rough idea of what is the project "EMBRYON" about.

proprietary    patented    therapy    safer    switzerland    approximate    double    simpler    15    forecasts    validated    newco    2020    outcomes    heavy    cheaper    ww    rate    subjective    lab    big    regulation    revenues    nearly    ethical    ph1    ph2    physician    leaving    2013    dollars    procedure    embryos    instruments    units    utero    prototype    handcrafted    partnership    ce    1400    invasive    favored    deeper    nikon    merges    gross    compliant    publish    finalize    specialists    45    global    patterns    social    cycles    reactivity    algorithms    rates    million    italy    trials    couples    six    infertility    scan    improves    generation    market    observations    deep    microscopy    microscope    fda    org    vitro    last    precision    pregnancy    embryon    fertilization    plan    costly    image    amongst    favoring    validation    identification    diagnostic    100    scientists    sales    shape    optimization    ll    issue    20    patients    morphological    reproductive    smarter    images    10    leader    cycle    innovations    extension    transferred    births    introduces    lifetime    imaging    clearance    acs    solutions    1200    clinical    ongoing    clinics    embryo    patents    billion    certify    innovation    automated    despite    easier    commercial    overcoming    ivf    software    predictors    stressful   

Project "EMBRYON" data sheet

The following table provides information about the project.

Coordinator		 ADVANCED COMPUTER SYSTEMS A.C.S. SPA 

Organization address
address: VIA DELLA BUFALOTTA 378
city: ROMA
postcode: 139
website: www.acsys.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website http://www.unbimbo.it/en/index.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ADVANCED COMPUTER SYSTEMS A.C.S. SPA IT (ROMA) coordinator 50˙000.00

Map

 Project objective

Infertility is a heavy social issue,experienced by nearly one in six couples during reproductive lifetime. In Vitro Fertilization (IVF) is growing 8-10% p.a.,to 1.5 million therapy cycles and 7.5 billion dollars in 2013. Despite stressful and costly procedures,IVF success rate is low (15-20% births/cycle),leaving big opportunities for innovation and process optimization. EMBRYON introduces to IVF clinics and specialists a last-generation diagnostic-imaging system,favoring better outcomes through deeper,smarter analysis of clinical images. It merges tailored image-processing software and algorithms,patented by ACS,with a high-end commercial IVF microscope.A prototype is under validation with top clinics in Italy and Switzerland,supported by Nikon Instruments (global leader in IVF microscopy). EMBRYON improves the key success factor of any IVF procedure:the identification of 1-2 embryos with best “pregnancy potential” to be transferred in utero,amongst 5-10 generated in vitro. EMBRYON’s precision is double than current handcrafted approaches,favoring higher success rates. It is safer (100% not invasive),thus simpler to certify and adopt,fully compliant with ethical regulation,easier to use (no change to lab procedures) and cheaper than similar products. Key innovations 1. Automated deep scan of embryo shape,overcoming today’s subjective and approximate observations carried by the physician 2. Proprietary algorithms for the measurement of complex morphological patterns,strong predictors of potential Sales forecasts are 1200-1400 units (40-45 M€ gross revenues) by 2020 in Europe and US,favored by: - High reactivity of the IVF sector (scientists/patients) to validated solutions improving outcomes - Commercial partnership with a global IVF microscopy leader In Ph1 we’ll finalize and publish the ongoing clinical studies and make a deep market analysis for Europe-US In Ph2 we plan CE/FDA clearance,WW extension of patents,3 trials in Europe-US,set-up of newco and sales org

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More